However, serpin B9 expression has been observed in multiple primary cancers, including lymphoma, melanoma, colon carcinoma, breast cancer, and lung cancer, in which it generally correlates with poor prognosis (102–107). This evidence concerns the gene SERPINB9 and melanoma.